| Outcomes | No. of Participants (studies) Follow up | Quality of the evidence (GRADE) | Relative effect (95% CI) | Anticipated absolute effects | |
|---|---|---|---|---|---|
| Risk with Standard treatment | Risk difference with TXA (95% CI) | ||||
| Post-operative blood loss - post 2003 | 120 (1 study) | MODERATEa due to risk of bias | The mean post-operative blood loss - post 2003 in the intervention groups was 16 lower (21.13 to 10.87 lower) | ||
| Length of stay | 83 (1 study) | LOWb due to risk of bias, imprecision | The mean length of stay in the intervention groups was 0.1 higher (0.37 lower to 0.57 higher) | ||
Majority of the evidence was at high risk of bias.
Confidence interval crosses one MID.
From: 6, Alternatives to blood transfusion for patients having surgery: Cell salvage and tranexamic acid
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.